ATXI

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Avenue Therapeutics Inc

PINK | ATXI

0.71

USD

$0.00

(

0.00%

)

At Close (As of Oct 23, 2025)

$2.26M

Market Cap

0.275

P/E Ratio

2.58

EPS

$2.63

52 Week High

$0.16

52 Week Low

HEALTHCARE

Sector

ATXI Chart

Recent Chart
Price Action

ATXI Technicals

Tags:

ATXI Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$11M
Selling General And Administrative $4.6M
Research And Development $6.6M
Operating Expenses $11M
Investment Income Net -
Net Interest Income $176K
Interest Income $176K
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax -$12M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$12M
Comprehensive Income Net Of Tax -
Ebit -
Ebitda -$11M
Net Income -$12M

Revenue & Profitability

Earnings Performance

ATXI Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $2.7M
Total Current Assets $2.7M
Cash And Cash Equivalents At Carrying Value $2.6M
Cash And Short Term Investments $2.6M
Inventory -
Current Net Receivables -
Total Non Current Assets $0
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $78K
Other Non Current Assets -
Total Liabilities $816K
Total Current Liabilities $816K
Current Accounts Payable $155K
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $0
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $661K
Other Non Current Liabilities -
Total Shareholder Equity $2.8M
Treasury Stock -
Retained Earnings -$103M
Common Stock -
Common Stock Shares Outstanding $13M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$9M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $9.8M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$12M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$11M
Selling General And Administrative $4.6M
Research And Development $6.6M
Operating Expenses $11M
Investment Income Net -
Net Interest Income $176K
Interest Income $176K
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax -$12M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$12M
Comprehensive Income Net Of Tax -
Ebit -
Ebitda -$11M
Net Income -$12M

ATXI Profile

Avenue Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Avenue Therapeutics, Inc. is a New York-based specialty pharmaceutical firm dedicated to developing and commercializing innovative therapies specifically designed for acute and intensive care settings. The company focuses on addressing critical unmet medical needs within hospitals by enhancing therapeutic products through its specialized expertise. With a commitment to improving patient outcomes, Avenue Therapeutics is poised to play a vital role in advancing healthcare through its strategic initiatives in specialized therapeutic areas.

WGRX
+206.52%
$1.23
BYND
-9.57%
$2.56
TOVX
+95.58%
$0.66
YYAI
-15.09%
$0.07
VIVK
+49.53%
$0.38
CGBS
-39.47%
$0.03
INTC
+1.36%
$38.68
F
+10.29%
$13.61
YDKG
-16.29%
$0.06
VHAI
0.00%
$0.00
DVLT
+50.44%
$3.38
BURU
-5.27%
$0.34
BITF
+5.71%
$4.16
IONZ
-14.59%
$3.98
NEUP
+49.62%
$6.06
ADTX
-5.55%
$0.28
AXDX
-61.36%
$0.03
AAL
+8.01%
$13.79
NVDA
+1.66%
$185.18
PLUG
-1.36%
$2.88
ABEV
+0.45%
$2.21
TSLA
-3.02%
$435.40
RGTI
+2.39%
$40.54
RIG
+1.79%
$3.96
VZ
-3.51%
$38.40
SCNX
-34.80%
$1.69
QLGN
+6.53%
$3.76
AMD
+7.17%
$251.84
QBTS
+6.73%
$33.15
JOBY
+1.29%
$15.67
DNN
+2.32%
$2.79
NOK
+1.54%
$6.26
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
ONDS
+9.06%
$7.70
WTO
-9.03%
$0.06
SRM
+53.27%
$10.30
SOFI
+3.93%
$29.18
T
+1.96%
$25.10
ADAP
-4.14%
$0.06
RF
+1.34%
$24.42
CAN
+6.22%
$1.86
NUAI
+43.86%
$5.68
LAES
+16.68%
$6.67
CIFR
+18.52%
$20.45
CUTR
-10.19%
$0.09
AIRE
-15.81%
$0.83
WLGS
-5.57%
$0.04
QS
+13.01%
$16.56
ETHD
-0.62%
$3.94
GPUS
+0.93%
$0.38
ETWO
0.00%
$3.30
ACHR
+3.75%
$11.32
NIO
+1.37%
$6.98
ASST
+6.45%
$0.92
NVTS
+4.97%
$14.28
AMC
-1.46%
$2.68
TLRY
+1.68%
$1.50
CLOV
+18.90%
$3.80
PBR
-0.25%
$11.80
AFMD
-34.94%
$0.18
QUBT
+1.69%
$16.21
RR
+11.45%
$6.04
IREN
+8.57%
$60.65
PLTR
+2.77%
$185.49
GRAB
+2.06%
$5.83
KDLY
+10.41%
$0.79
SNAP
+0.50%
$7.91
PCG
-1.68%
$16.30
BTBT
+6.85%
$3.97
OPI
-16.97%
$0.20
BULL
+2.30%
$11.08
RXRX
+1.65%
$5.82
RGTZ
-4.19%
$14.27
KLG
-9.05%
$13.35
AMZN
+1.62%
$224.69
GNTA
+90.71%
$6.16
AAPL
+1.52%
$263.52
GRYP
-10.38%
$1.38
BBD
-0.10%
$3.34
MODV
-25.22%
$0.43
IONQ
+3.96%
$61.72
UUUU
-0.11%
$21.23
MARA
+1.90%
$19.58
NRXS
-5.26%
$3.61
APLD
+2.93%
$34.36
BTG
-0.19%
$5.22
BAC
+1.56%
$52.56
LAZR
+23.66%
$2.09
WULF
+7.33%
$13.82
WU
+10.24%
$8.97
HOOD
+3.41%
$138.91
SMR
+1.38%
$38.07
DFLI
+12.38%
$1.27
RVPH
+16.12%
$0.65
XFOR
+27.50%
$3.94
BMNR
+2.29%
$50.31
PFE
+0.33%
$24.75
GOOGL
+3.14%
$261.05
UAMY
-10.52%
$11.73
WGRX
+206.52%
$1.23
BYND
-9.57%
$2.56
TOVX
+95.58%
$0.66
YYAI
-15.09%
$0.07
VIVK
+49.53%
$0.38
CGBS
-39.47%
$0.03
INTC
+1.36%
$38.68
F
+10.29%
$13.61
YDKG
-16.29%
$0.06
VHAI
0.00%
$0.00
DVLT
+50.44%
$3.38
BURU
-5.27%
$0.34
BITF
+5.71%
$4.16
IONZ
-14.59%
$3.98
NEUP
+49.62%
$6.06
ADTX
-5.55%
$0.28
AXDX
-61.36%
$0.03
AAL
+8.01%
$13.79
NVDA
+1.66%
$185.18
PLUG
-1.36%
$2.88
ABEV
+0.45%
$2.21
TSLA
-3.02%
$435.40
RGTI
+2.39%
$40.54
RIG
+1.79%
$3.96
VZ
-3.51%
$38.40
SCNX
-34.80%
$1.69
QLGN
+6.53%
$3.76
AMD
+7.17%
$251.84
QBTS
+6.73%
$33.15
JOBY
+1.29%
$15.67
DNN
+2.32%
$2.79
NOK
+1.54%
$6.26
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
ONDS
+9.06%
$7.70
WTO
-9.03%
$0.06
SRM
+53.27%
$10.30
SOFI
+3.93%
$29.18
T
+1.96%
$25.10
ADAP
-4.14%
$0.06
RF
+1.34%
$24.42
CAN
+6.22%
$1.86
NUAI
+43.86%
$5.68
LAES
+16.68%
$6.67
CIFR
+18.52%
$20.45
CUTR
-10.19%
$0.09
AIRE
-15.81%
$0.83
WLGS
-5.57%
$0.04
QS
+13.01%
$16.56
ETHD
-0.62%
$3.94
GPUS
+0.93%
$0.38
ETWO
0.00%
$3.30
ACHR
+3.75%
$11.32
NIO
+1.37%
$6.98
ASST
+6.45%
$0.92
NVTS
+4.97%
$14.28
AMC
-1.46%
$2.68
TLRY
+1.68%
$1.50
CLOV
+18.90%
$3.80
PBR
-0.25%
$11.80
AFMD
-34.94%
$0.18
QUBT
+1.69%
$16.21
RR
+11.45%
$6.04
IREN
+8.57%
$60.65
PLTR
+2.77%
$185.49
GRAB
+2.06%
$5.83
KDLY
+10.41%
$0.79
SNAP
+0.50%
$7.91
PCG
-1.68%
$16.30
BTBT
+6.85%
$3.97
OPI
-16.97%
$0.20
BULL
+2.30%
$11.08
RXRX
+1.65%
$5.82
RGTZ
-4.19%
$14.27
KLG
-9.05%
$13.35
AMZN
+1.62%
$224.69
GNTA
+90.71%
$6.16
AAPL
+1.52%
$263.52
GRYP
-10.38%
$1.38
BBD
-0.10%
$3.34
MODV
-25.22%
$0.43
IONQ
+3.96%
$61.72
UUUU
-0.11%
$21.23
MARA
+1.90%
$19.58
NRXS
-5.26%
$3.61
APLD
+2.93%
$34.36
BTG
-0.19%
$5.22
BAC
+1.56%
$52.56
LAZR
+23.66%
$2.09
WULF
+7.33%
$13.82
WU
+10.24%
$8.97
HOOD
+3.41%
$138.91
SMR
+1.38%
$38.07
DFLI
+12.38%
$1.27
RVPH
+16.12%
$0.65
XFOR
+27.50%
$3.94
BMNR
+2.29%
$50.31
PFE
+0.33%
$24.75
GOOGL
+3.14%
$261.05
UAMY
-10.52%
$11.73
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.